The US has opened a Section 301 investigation into Germany's drug pricing system, escalating trade pressure as Berlin reviews legislation to cut healthcare spending.
Amid Germany’s ongoing review of its healthcare spending, the US government has started a trade investigation into the European country’s drug pricing system.
The investigation …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
US opens trade probe into German drug pricing, escalating pressure on Europe | Euractiv
US launches trade probe into Germany over medicine prices
US launches Section 301 probe of Germany over pharmaceutical pricing
US probes Germany's drug pricing policies, opens door to tariffs
US launches trade investigation into Germany over drug pricing
U.S. opens tariff probe targeting Germany’s drug pricing policies
US launches trade probe on Germany over pharma pricing
US steps up pressure on Berlin over drug prices
US launches Germany pharma pricing probe, raising threat of new tariffs
US launches tariff investigation into Germany over pharmaceuticals, escalating trade tensions
The announcement comes as Germany tries to cut rising healthcare costs
Washington accuses Berlin of keeping the prices it pays for new medicines too low, while the US market pays significantly more…
The US Trade Representative launched a Section 301 investigation into Germany's pharmaceutical pricing, alleging underpayment for…
The US has launched a trade probe into Germany's pharmaceutical pricing, alleging it unfairly burdens American commerce and…
America has started a trade probe into Germany's plan to cut pharmaceutical spending. U.S. Trade Representative Jamieson Greer…
U.S. Trade Representative Jamieson Greer said Germany's proposal to reduce spending on medicines was "a serious step backwards."
